Wednesday, September 2, 2026

Rigaku Launches CT Lab HR160 High-Resolution X-ray CT System

 - Developed in collaboration with Excillum for battery, semiconductor devices, and advanced materials analysis -


 


(BUSINESS WIRE)--Rigaku Corporation, a global solutions partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (Headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), today announced the launch of the CT Lab HR160, a high-resolution X-ray computed tomography (CT) system for battery, semiconductor devices, electronic components, and advanced materials analysis. The system is developed in collaboration with Excillum AB, the global source for X-ray innovation (Headquarters: Stockholm, Sweden; CEO: David Lindblom; “Excillum”).


CT Lab HR160 combines Rigaku’s X-ray CT imaging expertise with Excillum’s NanoTube N3 X-ray source. Operating at up to 160 kV to support a wide range of sample types, the system achieves true 250 nm spatial resolution — an industry-leading level for CT systems in its class. This enables detailed, non-destructive 3D imaging of fine internal structures and defects that can be difficult to observe with conventional laboratory CT systems.


Its cone-beam geometry allows users to adjust the field of view and resolution without changing the X-ray source, detector, simplifying operation across different samples and imaging requirements. The system is designed for applications such as solid-state batteries, semiconductor devices, multilayer ceramic capacitors (MLCCs), and power electronics, where internal inspection plays an increasingly important role in research, development, quality evaluation, and failure analysis.


As electronic components and advanced materials become smaller, more complex, and higher-performing, researchers and manufacturers need analytical tools that can reveal increasingly fine internal features with greater precision. Built on the combined strengths of Rigaku and Excillum, CT Lab HR160 addresses these needs by providing a high-resolution laboratory CT environment that supports faster development, improved product quality, and more advanced failure analysis.


“CT Lab HR160 gives customers a new option for addressing increasingly complex analytical challenges in advanced materials and electronic devices. By providing high-resolution CT capabilities in a laboratory environment, we aim to support faster decision-making across research, development, quality evaluation, and failure analysis,” said Kiyoshi Ogata, General Manager of the Product Division, Rigaku.


“We are pleased to see Excillum’s X-ray source technology integrated into Rigaku’s new CT Lab HR160 system. This collaboration brings together the strengths of both companies and creates new opportunities to support R&D and manufacturing at the forefront of advanced industries,” said Sara Haack, Chief Commercial Officer, Excillum AB.


Additional information about CT Lab HR160 is available on the Rigaku website:

Rigaku CT Lab HR160 product page


About the Rigaku Group

Since its establishment in 1951, the engineering professionals of the Rigaku group have been dedicated to benefiting society with leading-edge technologies, notably including its core fields of X-ray and thermal analysis. With a market presence in 136 countries and regions and some 2,000 employees from 9 global operations, Rigaku is a solution partner in industry and research analysis institutes. Our overseas sales ratio has reached approximately 70% while sustaining an exceptionally high market share in Japan. Together with our customers, we continue to develop and grow. As applications expand from semiconductors, electronic materials, batteries, environment, resources, energy, life science to other high-tech fields, Rigaku realizes innovations “To Improve Our World by Powering New Perspectives.”

For details, please visit: rigaku-holdings.com/english


About Excillum

Excillum is the global source for X-ray innovation. We develop, manufacture, and service the world’s brightest and most advanced industrial and laboratory X-ray sources. In close collaboration with best-in-class scientific, industrial and system integration partners we enable new science, improve medicine and enhance manufacturing. Headquartered in Stockholm, Sweden, Excillum is pushing the limits of X-ray source technologies since 2007. excillum.com


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260901074099/en/



Permalink

https://www.aetoswire.com/en/news/1092026569977


Contacts

Press Contact:

Sawa Himeno

Director, Communications Dept., Rigaku Holdings Corporation

prad@rigaku.co.jp


Sara Haack, Chief Commercial Officer

sara.haack@excillum.com

+46 721 436 983

BeOne Medicines Announces Voluntary Agreement with U.S. Government to Expand Access to Innovative Cancer Medicines

 SAN CARLOS, Calif. - Tuesday, 01. September 2026 AETOSWire  



Agreement advances patient access and strengthens BeOne's long-term commitment to U.S. innovation and manufacturing


(BUSINESS WIRE) -- BeOne Medicines, Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne's longstanding commitment to patient access and investment in research and scientific innovation.


John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said:

“At BeOne, we believe every patient should benefit from innovative cancer therapies. We appreciate the Trump Administration’s commitment to advancing solutions that broaden access and scientific progress for American patients. This agreement reflects our purpose to reach more patients as we expand our U.S. investment in additional research, development, and manufacturing to deliver breakthrough cancer treatments worldwide.”


Improved access to oncology medicines for patients

This announcement reflects BeOne’s participation in the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) Model and the company’s commitment to pricing future FDA-approved products in line with other key developed markets.


Increased manufacturing and investment

Through continued investments in U.S. manufacturing, BeOne is enhancing supply continuity and manufacturing flexibility while supporting patient access to innovative medicines.


BeOne entered into an onshoring agreement with the U.S. government, securing an exemption from Section 232 pharmaceutical tariffs that recognizes the company’s significant and ongoing investments in US. manufacturing.


The company recently announced a $300 million onshoring investment in its flagship clinical and commercial-stage manufacturing and research and development facility in Hopewell, NJ, bringing total U.S. manufacturing investment to more than $1 billion. The expansion will add small-molecule manufacturing capacity, create approximately 120 full-time jobs and enhance BeOne’s ability to manufacture medicines in the states and advance its oncology pipeline of more than 35 clinical- and commercial-stage assets.


The U.S. is an important hub for BeOne's scientific, clinical and manufacturing operations. BeOne employs more than 2,000 U.S. colleagues within a global team of more than 12,000 across six continents. In 2025, the company generated nearly $2 billion in direct U.S. economic impact and invested $1 billion in U.S. research and development. BeOne is also advancing one of oncology's broadest pipelines through 93 clinical trials at approximately 1,100 sites across 45 states and one territory, supported by more than 650 investigators.


About BeOne

BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company has a growing global team spanning six continents who are driven by scientific excellence and exceptional speed to reach more patients than ever before. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram.


Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws, including statements regarding BeOne helping more eligible patients in the U.S. access innovative cancer medicines while supporting continued investment in U.S. research, manufacturing and scientific innovation; BeOne reaching patients around the world faster, more reliably and at greater scale; BeOne pricing future FDA-approved products in line with other key developed markets; BeOne’s commitment to continued investment in U.S. manufacturing, stronger supply chain resilience, and support of patient access to innovative medicines; and BeOne’s plans, commitments, aspirations, and goals under the heading “About BeOne.” Actual results may differ materially from those indicated in the forward-looking statements as a result of various important factors, including BeOne’s ability to demonstrate the efficacy and safety of its drug candidates; the clinical results for its drug candidates, which may not support further development or marketing approval; actions of regulatory agencies, which may affect the initiation, timing, and progress of clinical trials and marketing approval; BeOne’s ability to achieve commercial success for its marketed medicines and drug candidates, if approved; BeOne’s ability to obtain and maintain protection of intellectual property for its medicines and technology; BeOne’s reliance on third parties to conduct drug development, manufacturing, commercialization, and other services; BeOne’s limited experience in obtaining regulatory approvals and commercializing pharmaceutical products and its ability to obtain additional funding for operations and to complete the development of its drug candidates and achieve and maintain profitability; and those risks more fully discussed in the section entitled “Risk Factors” in BeOne’s most recent quarterly report on Form 10-Q, as well as discussions of potential risks, uncertainties, and other important factors in BeOne’s subsequent filings with the U.S. Securities and Exchange Commission. All information in this press release is as of the date of this press release, and BeOne undertakes no duty to update such information unless required by law.


To access BeOne media resources, please visit our Newsroom.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260831047788/en/



Permalink

https://www.aetoswire.com/en/news/0109202656974


Contacts

Investor Contact

Liza Heapes

+1 857-302-5663

ir@beonemed.com


Media Contact

Kyle Blankenship

+ 1 667-351-5176

media@beonemed.com


 

Tuesday, September 1, 2026

Perma-Pipe and Welspun Announce Memorandum of Understanding to Establish Pipe Manufacturing and Coating Facilities in Jordan

 THE WOODLANDS, Texas - Tuesday, 01. September 2026 AETOSWire  


Strategic Partnership to Establish Integrated Pipe Manufacturing and Coating Capabilities to Support Water, Oil & Gas, and Infrastructure Projects in Jordan and the Levant Region.


(BUSINESS WIRE) -- Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) (“Perma-Pipe” or the “Company”), a global leader in engineered pipe solutions specialising in anti-corrosion coatings, insulation solutions, containment systems, custom fabrication and leak detection, today announced that it has signed, together with Welspun Corp Limited (“Welspun”), a Memorandum of Understanding (“MOU”) with the developers of Jordan’s National Water Carrier Project and the Government of the Hashemite Kingdom of Jordan to advance the development of pipe manufacturing and advanced coating facilities in Jordan. The parties intend to establish a joint venture to support the development and operation of these facilities.


Transaction Description


Under the terms of the MOU, Perma-Pipe and Welspun have partnered to establish an integrated pipe manufacturing and coating platform in Jordan capable of serving major water, oil and gas, energy, and infrastructure projects in the Kingdom and across surrounding regional markets.


The partnership is expected to bring together Welspun’s large-diameter steel pipe manufacturing capabilities and Perma-Pipe’s expertise in anti-corrosion coating systems designed to protect pipelines from corrosion and extend service life, engineered piping solutions and project execution expertise.


Next Steps


Perma-Pipe, Welspun, and the project developers are engaged in the technical, commercial, financing and regulatory requirements associated with the project, including facility design, manufacturing capacity, coating technologies, market requirements and applicable approvals. Additional details regarding Perma-Pipe’s investment in the JV, ownership structure, capacity, and project timeline will be announced as the project progresses and definitive agreements are completed.


Strategic Regional Platform


The partnership is intended to create a strategically located regional manufacturing hub that can support large-scale infrastructure programs, strengthen regional supply chains, increase local value creation and develop skilled technical capabilities in Jordan. Over time, it could also support infrastructure development and reconstruction requirements in Syria, Lebanon, Iraq and Gaza, as well as potential future opportunities associated with the development and rerouting of regional oil and gas infrastructure toward the Port of Aqaba.


Saleh Sagr, President and Chief Executive Officer of Perma-Pipe, commented:


“Our proposed investment in Jordan is consistent with Perma-Pipe’s strategy of expanding its global manufacturing and coating footprint in strategically important markets where long-term infrastructure investment is expected to create attractive growth opportunities. Jordan’s geographic position is particularly important to our vision, offering a manufacturing base in the Kingdom that can serve as a gateway to markets across the Levant and broader Middle East and provide a platform from which to tap the significant infrastructure investment we expect in the region over the coming years.


“Perma-Pipe and Welspun bring highly complementary capabilities to this opportunity, creating a strong foundation for an integrated manufacturing platform that can serve customers from within the region. The proposed platform would further extend Perma-Pipe’s ability to provide localized manufacturing and coating solutions while improving customer responsiveness, strengthening supply-chain resilience.


“We are pleased to be working with Welspun and the project developers on this initiative and appreciate the support of the Government of Jordan. We believe this project has the potential to become an important regional manufacturing center and contribute meaningfully to Jordan’s industrial development, supply-chain capabilities and long-term economic growth.


“We would also like to express our sincere appreciation to the Jordanian Government for their support and engagement in helping facilitate this important opportunity. Their continued commitment to strengthening commercial ties between the United States and Jordan and supporting American companies pursuing strategic international investments has been instrumental in advancing this initiative,” Mr. Sagr concluded.


Vipul Mathur, Managing Director and Chief Executive Officer of Welspun Corp Limited, commented:


“This JV with Perma-Pipe aligns with investments we are making in onshore and offshore oil and gas projects, water infrastructure development, reconstruction opportunities across the Middle East, and emerging hydrogen and carbon capture utilization and storage initiatives, that are expected to support sustained pipeline demand.


“The combination of our pipe manufacturing expertise and Perma-Pipe's innovative, advanced coating and engineered solutions capabilities can create a differentiated offering as we seek to build stronger customer relationships. We look forward to working with Perma-Pipe, the project developers and the Government of Jordan to advance this initiative and develop a long-term industrial presence in the Kingdom.”


H.E. Eng. Raed Abu Soud, Minister of Water and Irrigation of the Hashemite Kingdom of Jordan, said:


“Jordan welcomes strategic investments that strengthen our national manufacturing capabilities and support the development of critical water infrastructure. The Government, with directions of HM King Abdullah, are supporting these significant investments to strengthen our water security among other sectors, and these require reliable, high-quality infrastructure together with strong local supply-chain capabilities. We welcome the proposed partnership involving Perma-Pipe and Welspun, which represents an important opportunity to establish advanced pipe manufacturing and coating capabilities in the Kingdom, and to increase local participation in major infrastructure projects.”


Supporting Jordan’s Water Security and Infrastructure Development


Jordan’s National Water Carrier Project (“NCP”) is one of the Kingdom’s most significant strategic infrastructure initiatives, designed to enhance long-term water security and address growing water supply challenges. The project is expected to transport desalinated water from the Gulf of Aqaba to communities across Jordan through a major pipeline network and associated water infrastructure.


The development of local pipe manufacturing and advanced coating capabilities is intended to support the NCP’s substantial infrastructure requirements while creating a long-term industrial platform capable of serving future water, energy and infrastructure projects in Jordan and the Levant region. Beyond the NCP, the planned facilities are expected to position the future joint venture to pursue additional opportunities in Jordan and across regional markets.


About Perma-Pipe International Holdings, Inc.


Perma-Pipe International Holdings, Inc. (Nasdaq: PPIH) is a global leader in engineered piping and corrosion protection solutions. The Company provides pre-insulated piping systems, leak detection systems, anti-corrosion coatings and related engineered products and services to customers across the energy, district energy, infrastructure, industrial, Oil & Gas, water transmission, and other critical infrastructure markets.


Perma-Pipe operates manufacturing and service facilities across North America, Middle East, North Africa, India and other strategic markets, enabling the Company to serve customers globally while providing local manufacturing and engineering capabilities.


For more information, visit www.permapipe.com.


About Welspun Corp Limited


Welspun Corp Limited is a flagship company of the Welspun Group and a leading global manufacturer of large-diameter line pipes. Welspun offers a broad range of line pipe products, including LSAW, HSAW, HFW and HFIW pipes, as well as specialised coating, double jointing and bending capabilities. Its products serve major oil and gas, water and infrastructure applications.


Vipul Mathur is Managing Director and Chief Executive Officer of Welspun Corp Limited.


For more information, visit www.welspun.com


Forward-Looking Statements


Certain statements and other information contained in this press release that can be identified by the use of forward-looking terminology constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby, including, without limitation, statements regarding the expected future performance and operations of the Company. These statements should be considered as subject to the many risks and uncertainties that exist in the Company's operations and business environment. Such risks and uncertainties include, but are not limited to, the following: (i) the impact of a health pandemic on the Company's results of operations, financial condition and cash flows; (ii) fluctuations in the price of oil and natural gas and its impact on the customer order volume for the Company's products; (iii) the Company's ability to comply with all covenants in its credit facilities; (iv) the Company’s ability to repay its debt and renew expiring international credit facilities; (v) the Company’s ability to effectively execute its strategic plan and achieve profitability and positive cash flows; (vi) the impact of global economic weakness and volatility; (vii) fluctuations in steel prices and the Company’s ability to offset increases in steel prices through price increases in its products; (viii) the timing of order receipt, execution, delivery and acceptance for the Company’s products; (ix) decreases in government spending on projects using the Company’s products, and challenges to the Company’s non-government customers’ liquidity and access to capital funds; (x) the Company’s ability to successfully negotiate progress-billing arrangements for its large contracts; (xi) aggressive pricing by existing competitors and the entrance of new competitors in the markets in which the Company operates; (xii) the Company’s ability to purchase raw materials at favorable prices and to maintain beneficial relationships with its suppliers; (xiii) the Company’s ability to manufacture products free of latent defects and to recover from suppliers who may provide defective materials to the Company; (xiv) reductions or cancellations of orders included in the Company’s backlog; (xv) the Company's ability to collect an account receivable related to a project in the Middle East; (xvi) risks and uncertainties related to the Company's international business operations; (xvii) the Company’s ability to attract and retain senior management and key personnel; (xviii) the Company’s ability to achieve the expected benefits of its growth initiatives; (xix) the Company’s ability to interpret changes in tax regulations and legislation; (xx) the Company's ability to use its net operating loss carryforwards; (xxi) reversals of previously recorded revenue and profits resulting from inaccurate estimates made in connection with the Company’s percentage-of-completion revenue recognition; (xxii) the Company’s failure to establish and maintain effective internal control over financial reporting; and (xxiii) the impact of cybersecurity threats on the Company’s information technology systems. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this press release and we undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, which are available at https://www.sec.gov and under the Investor Center section of our website (http://investors.permapipe.com).


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260901617785/en/



Permalink

https://www.aetoswire.com/en/news/0109202656991


Contacts

Saleh Sagr, President and CEO


Perma-Pipe Investor Relations

investor@permapipe.com


847.929.1200

Global Tech Sales Forecast to Reach $1.4 Trillion in 2026, Even as 56% of Consumers Delay Purchases, NIQ Finds

CHICAGO - Tuesday, 01. September 2026


Global study finds price-sensitive shoppers will still pay more when products deliver clear, lasting benefits


(BUSINESS WIRE) -- Global sales of consumer technology and durable goods are forecast to reach $1.4 trillion in 2026, up 5.1% year over year, even as 56% of consumers say they have delayed a technology purchase because of price or while waiting for a discount, according to new research from NIQ (NYSE: NIQ), the Official Global Insights Partner of IFA.


Released ahead of IFA 2026, which kicks off in Berlin on Sept. 4, 2026, NIQ today released its annual “State of Tech & Durables” report. Consumer Tech Trends 2027: How to Win When Every Purchase Must Be Justified examines how years of economic volatility have transformed technology purchasing behavior and what manufacturers and retailers must do to remain competitive.


Key findings include:


Global T&D sales are forecast to reach $1.4 trillion in 2026, up 5.1% year over year


63% of T&D consumers exhibit high price sensitivity


60% prioritize brands that offer "good value for money"


56% have delayed a tech purchase because a product was too expensive or they were waiting for discounts


Consumers rank durability, quality, convenience, and trust ahead of affordability when defining value


Drawing on a survey of 17,000 adult consumers across 17 markets and NIQ's global sales intelligence, the report finds that consumers are no longer evaluating purchases with a simple question of affordability in mind. Instead, they are increasingly asking whether a product will continue to feel worthwhile long after the purchase has been made. This behavioral shift is influencing premiumization trends, replacement cycles, innovation priorities, and pricing strategies across technology categories.


"Consumers still want innovation, but they increasingly require a compelling reason to buy,” said Perry James, Global Head of Tech & Durables at NIQ. “Today’s buyers are asking, ‘Will this purchase still feel worth it six months from now?’ The brands that grow in 2027 will be those that make value obvious, reduce uncertainty, and help consumers confidently justify their purchase decisions.”


Consumer Tech Trends 2027 reveals that while consumers remain highly price-sensitive, they’re still willing to pay premium prices when products deliver meaningful benefits. Categories such as AI-enabled PCs, premium smartphones, advanced vacuum cleaners, and larger-screen televisions continue to outperform broader category averages when consumers clearly understand the advantage being offered.


NIQ, the Official Global Insights Partner of IFA, will present findings from this report and other Tech & Durables trends at the IFA 2026 conference on Sept. 4, 2026. To learn more about the report, visit niq.com/consumer-tech-trends-2027.


FAQs


What is Consumer Tech Trends 2027?


Consumer Tech Trends 2027: How to Win When Every Purchase Must Be Justified is NIQ's annual State of Tech & Durables report. Based on a survey of 17,000 consumers across 17 markets and NIQ's global sales intelligence, the report examines how changing consumer attitudes toward value, affordability, and technology purchases are reshaping the consumer technology market.


What is the report's main finding?


The report finds that consumers are increasingly evaluating technology purchases based on long-term value rather than affordability alone. Shoppers are asking whether a product will continue to feel worthwhile after purchase, influencing how they evaluate features, pricing, and brands.


Why are consumers delaying technology purchases?


According to the report, 56% of consumers have delayed a technology purchase because the product was too expensive or because they were waiting for a discount. Price sensitivity remains high, even as consumers continue to seek innovation and performance.


How price-sensitive are today's technology consumers?


The report finds that 63% of consumers exhibit high price sensitivity, while 60% prioritize brands that offer good value for money. This suggests consumers are carefully weighing purchase decisions and looking for clear evidence that products justify their cost.


If consumers are price-sensitive, why are premium products still growing?


Consumers remain willing to pay premium prices when products deliver meaningful and clearly understood benefits. Categories such as AI-enabled PCs, premium smartphones, advanced vacuum cleaners, and larger-screen televisions continue to outperform broader category averages when consumers perceive strong value.


What do consumers consider when defining value?


The report finds that consumers rank durability, quality, convenience, and trust ahead of affordability when assessing value. Increasingly, consumers are looking beyond price alone and evaluating the total benefit a product provides over time.


What do these findings mean for manufacturers and retailers?


Technology brands must do more than introduce new features. Success increasingly depends on helping consumers understand the value of innovation, reducing uncertainty, and clearly communicating the long-term benefits of ownership.


What is the outlook for the global technology market?


NIQ forecasts global Tech & Durables sales will reach $1.4 trillion in 2026, representing 5.1% year-over-year growth. The report suggests future growth will be driven by products that clearly demonstrate value and help consumers confidently justify purchases.


About NIQ


NielsenIQ (NYSE: NIQ) is a leading consumer intelligence company, delivering the most complete and trusted understanding of consumer buying behavior and revealing new pathways to growth. By combining an unmatched global data footprint and granular consumer and retail measurement with decades of AI modeling expertise, NIQ builds decision systems that help companies turn complex data into confident action.


With operations in more than 90 countries, NIQ covers approximately 82% of the world’s population and more than $7.4 trillion in global consumer spend. Through cloud-based platforms, advanced analytics and AI-driven insights, NIQ delivers The Full View™—helping brands and retailers understand what consumers buy, why they buy it, and what to do next.


For more information, please visit www.niq.com.


© 2026 Nielsen Consumer LLC. All Rights Reserved.


All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them.


Forward Looking Statement


This press release about NIQ’s Consumer Tech Trends 2027 report on global consumer technology and durables sales may contain forward-looking statements regarding anticipated consumer technology purchasing behavior, global T&D sales forecasts, category growth trends, and industry developments. These statements reflect current expectations and projections based on available data, historical patterns, and various assumptions. Words such as ‘forecast,’ ‘will,’ ‘suggests’ and similar expressions are intended to identify forward-looking statements.


These statements are not guarantees of future outcomes and are subject to inherent uncertainties, including changes in consumer preferences, economic conditions, technological advancements, and competitive dynamics. Actual results may differ materially from those expressed or implied in these statements. While we strive to base our insights on reliable data and sound methodologies, we undertake no obligation to update any forward-looking statements to reflect future events or circumstances, except to the extent required by applicable law.


#NIQ-General


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260901758503/en/



Permalink

https://www.aetoswire.com/en/news/0109202656980


Contacts

Media Contact: media.relations@nielseniq.com

Mary Kay Unveils New Global Brand Platform – Beauty Is More Beautiful Shared™ – Reclaiming Beauty as a Shared Experience

 DALLAS - Tuesday, 01. September 2026 AETOSWire  



With Largest Consumer-Facing Campaign In Company History Mary Kay Enters Its New Era Of Reach And Impact


 


(BUSINESS WIRE)--Today, Mary Kay Inc., the iconic beauty and entrepreneurship brand founded by the bold visionary Mary Kay Ash, announced Beauty Is More Beautiful Shared™, its largest-ever global consumer-facing campaign and a long-term brand strategy designed to drive its next era of growth. Launching across 40 markets worldwide, the campaign reintroduces Mary Kay to a new generation of consumers by celebrating a timeless truth at the heart of the brand: Beauty Is More Beautiful Shared™ and bridging the love for Mary Kay across generations.


“Beauty Is More Beautiful Shared™ is a reflection of who we are and what we have always stood for: women supporting women,” said Ryan Rogers, Chief Executive Officer of Mary Kay Inc. “As we enter our next era of growth, we are celebrating and empowering every Mary Kay woman, from our Independent Beauty Consultants to customers, expanding our reach and impact and bringing our promise of confidence, opportunity, and human connection to life in bold, relevant, and compelling new ways.”


Through Beauty Is More Beautiful Shared™ Mary Kay directly addresses the shift in beauty, tapping into a profound cultural longing for community and connection that the world, and generations of women, are feeling more than ever. The campaign champions connection, sisterhood, and community in an increasingly digital world, reinforcing Mary Kay's unique point of view and modern relevance as a beauty brand built not only on products, but on relationships.


“In a world where beauty has often resonated as a solo act, we're reclaiming beauty as a shared experience, celebrating the power of sharing, supporting, and uplifting one another. Beauty Is More Beautiful Shared™ brings the enduring power of womanhood and shared connection into the way Mary Kay approaches beauty,” said Dr. Lucy Gildea, Chief Brand and Scientific Officer of Mary Kay. “Through this master brand campaign, we are sharing the emotional connection and timeless purpose at the heart of our brand with consumers around the world, celebrating the transformative power of our iconic products and the difference our brand makes in women’s lives and communities. This campaign is an invitation to rediscover what has always made Mary Kay different, and to experience the beauty of what’s possible when we share it.”


Beauty Is More Beautiful Shared™ global campaign was developed in partnership with Grey, through an all women-team bringing together a modern creative vision and Mary Kay's enduring heritage to shape the next chapter of the brand.


“Beauty Is More Beautiful Shared™ elevates Mary Kay as the contemporary, confident brand it is, not just in strategic vision, but in its visual execution,” said Agnes Fischer, U.S. Chief Executive Officer of Grey. “Working alongside an A-list director from the next generation, Olivia De Camps, we’ve built a creative narrative that reveals a powerful truth about Mary Kay. The campaign meets today’s women where they are, re-igniting the iconic Mary Kay brand and making it unmistakably relevant.”


Beauty Is More Beautiful Shared™ was intentionally designed to support the success of Mary Kay Independent Beauty Consultants. With a message that amplifies community and transformation, this bold campaign will broaden awareness and foster a desire to purchase Mary Kay products and to connect with Independent Beauty Consultants through their personal digital storefront at Mary Kay.


GLOBAL ACTIVATIONS: Beauty Is More Beautiful Shared™ will be powered through a comprehensive media mix tailored to meet the next generation of beauty and community lovers where they are, further amplifying the campaign's reach and impact.


The campaign rollout includes an effective blend of online amplification through digital platforms, social media, influencer partnerships, and “real world” bold, out-of-home placements and events.

A wave of high visibility, unmissable, experiential consumer events designed to bring Gen Z together in real life will kick off in New York this month, engaging a global community across 40 markets from Brazil, Mexico and China to Kazakhstan, the Czech Republic and more.

Topping The Global Charts:


Mary Kay ranked #8 out of 5,500 brands on Forbes’s 2026 Best Brands for Social Impact1 moving up from stellar #9 achieved in 2025. Mary Kay is the only beauty brand in the Top 15.

Mary Kay ranked #2 on Forbes 2026 Best Customer Service list moving up from #93 in 20252. Mary Kay is the only Beauty brand in the Top 15 and the only direct-selling company in the Top 50.

Mary Kay is named to Happi’s Top 50 U.S. Companies 2026 Report, cinching Mary Kay Ash’s favorite number 13 ranking3.

Discover Mary Kay’s Beauty Is More Beautiful Shared™ Campaign:


Watch the Campaign Film here.

Experience the Campaign Creatives here.

Learn More About Campaign Film Director Olivia De Camps.


ABOUT MARY KAY


For more than 60 years, Mary Kay has empowered generations of women around the world to discover beauty together, build meaningful futures and find a community of women who celebrate one another. Founded by Mary Kay Ash in 1963, the global beauty company has connected women across 40 markets through innovative skincare, color cosmetics, fragrances, and wellness products. Mary Kay transforms purpose into action by advancing causes that support women and families, investing in scientific innovation, and working toward a more sustainable future. At its core, Mary Kay is dedicated to enriching women's lives and creating opportunities for women to thrive together. Learn more at marykayglobal.com. Find us on Facebook, Instagram, and LinkedIn.


ABOUT GREY


Grey’s mission is to create Famously Effective ideas that move people, businesses, and the world forward, harnessing the power of creativity to solve business challenges and drive growth for some of the world’s most influential brands and companies, including Procter & Gamble, Volvo, Haleon, Circle K, and The Coca-Cola Company. That commitment to effectiveness has earned Grey a Grand Effie in every market where it operates. Grey was recognized as a 2025 Fast Company World Changing Ideas winner and earned 26 Lions at the 2026 Cannes Lions International Festival of Creativity, contributing to Ogilvy’s Network of the Year honors. Newsweek also named Grey a Top 100 Global Most Loved Workplace in 2024 and one of America's Greatest Workplaces for Women and Professional Services in 2025. Grey is part of WPP, the trusted growth partner for the world's leading brands. Powered by exceptional talent and our agentic marketing platform WPP Open, WPP unites cutting-edge media intelligence and data solutions, creativity, production, enterprise solutions and expert strategic counsel.


____________________


1


Alan Schwarz (March 17, 2026). Forbes - Best Brands For Social Impact 2026. https://www.forbes.com/lists/best-brands-social-impact/


2


Alan Schwarz (October 14, 2025). Forbes - Best Customer Service 2026. https://www.forbes.com/lists/best-customer-service/


3


Happi’s Top 50 Report. https://www.happi.com/top-companies-reports/top-50-us-companies/


 


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260901735460/en/



Permalink

https://www.aetoswire.com/en/news/1092026569955


Contacts

Mary Kay Inc. Corporate Communications

newsroom.marykay.com

972.687.5332 or media@mkcorp.com

MEX Exchange, Part of MultiBank Group, Announces Senior Leadership Appointments

DUBAI, United Arab Emirates - Monday, 31. August 2026


    David Ogg appointed Vice Chairman and Brian Andreyko named CEO

 

(BUSINESS WIRE)--MEX Exchange, the institutional electronic trading platform of MultiBank Group, has announced two senior leadership appointments, with David Ogg promoted to Vice Chairman and Brian Andreyko promoted to Chief Executive Officer. The appointments strengthen the company’s leadership as it advances the development of its institutional electronic trading platform.

David Ogg brings more than four decades of experience in foreign exchange trading and trading technology and is widely recognised within the institutional FX industry as the “Father of the ECN.” He founded HotspotFX in 1999, the first institutional FX electronic communications network, before going on to establish LavaFX and Ogg Trading. His career has also included senior roles at Credit Suisse, Lehman Brothers, HSBC and Dresdner Kleinwort Benson, as well as work with Bloomberg and Citibank on institutional FX trading solutions. He has been inducted into the Profit & Loss Hall of Fame.

Commenting on his appointment, David Ogg, Vice Chairman of MEX Exchange, said: “Institutional FX has evolved considerably over the past several decades, but there remains significant scope for innovation in how liquidity is accessed, matched and executed. At MEX Exchange, our focus is on combining deep market expertise with advanced technology to build an institutional trading venue that addresses the evolving requirements of market participants globally. I look forward to supporting the company’s strategic direction in my new role as Vice Chairman.”

Brian Andreyko brings over 30 years of experience in financial technology and institutional markets, with a track record of building, scaling and leading electronic trading businesses. He previously served as Chief Operating Officer and Chief of Staff at Currenex, and as Executive Vice President and Head of EBS at ICAP. He also served as CEO of MakoFX/Liquidity Pool and Chief Business Officer at TradAir, both of which were subsequently acquired.

Brian Andreyko, CEO of MEX Exchange, said: “MEX Exchange has a clear opportunity to bring a differentiated proposition to the institutional trading market. My priority as CEO will be to translate our technology and market expertise into a scalable platform that delivers speed, efficiency and a strong execution experience bringing together Emerging Market and Global participants. I look forward to working closely with David and the wider team as we move into the next stage of the company’s growth.”

The appointments form part of MEX Exchange’s continued investment in its leadership and institutional capabilities, supporting its ambition to expand its presence across global electronic trading markets.

ABOUT MULTIBANK GROUP

MultiBank Group, established in California, USA in 2005, is a global leader in financial derivatives, serving over 2 million clients across 100 countries, and boasts a daily trading volume that exceeds $35 billion. Renowned for its innovative trading solutions, robust regulatory compliance, and exceptional customer service, the Group offers an array of brokerage services and asset management solutions. It is regulated across five continents by 18+ of the most reputable financial authorities globally. The group’s award-winning trading platforms offer up to 1000:1 leverage on a diverse range of products, including Forex, Metals, Shares, Commodities, Indices, and Cryptocurrencies. MultiBank Group has received over 80 financial awards recognizing its trading excellence and regulatory compliance. For more information, visit MultiBank Group’s www.multibankgroup.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260831401493/en/

Permalink
https://www.aetoswire.com/en/news/3108202656968

Contacts

Nikolas Neofytou
nikolas.neofytou@multibankfx.com

Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis


 GRONINGEN, Netherlands - 

(BUSINESS WIRE)--QPS Holdings, LLC (QPS) today announced a significant renewal of its elemental bioanalysis infrastructure through the acquisition of two PerkinElmer NexION® 2200 inductively coupled plasma mass spectrometry (ICP-MS) systems to be housed in its Netherlands laboratories. The new instruments will replace two Agilent 7700 ICP-MS systems currently operating within the bioanalysis department. The NexION® 2200 platform was selected to support robust trace-element analysis, effective management of analytical interferences, reliable performance with challenging sample matrices, and efficient laboratory operations.


The investment is part of a broader upgrade and renewal program focused on maintaining a modern, reliable, and sustainable mass spectrometry capabilities across QPS global laboratory facilities. In addition to replacing established analytical equipment, the upgrade encompasses instrument qualification, method transfer, workflow optimization, employee training, and long-term lifecycle management.


QPS Netherlands will introduce the new instruments through a controlled implementation and qualification process. Existing methods will be assessed and transferred using appropriate comparability, bridging, or validation activities, depending on their intended use and regulatory status. This approach is designed to maintain continuity for ongoing studies while establishing a renewed platform for future method development and validation.


“ICP-MS is an important part of our bioanalytical offering, particularly for programs requiring sensitive and selective quantification of elements in complex biological matrices,” said Fred van Heuveln, QPS Director, Bioanalysis. “By replacing both systems at the same time, we are creating an upgraded analytical platform that will ensure reliable project execution through efficient method deployment and sample analysis, while providing a platform for the evolving requirements of our clients.”


The two-system configuration will provide operational flexibility and redundancy. Standardizing the ICP-MS platform is expected to simplify training, maintenance, method transfer and routine laboratory support while helping QPS manage study schedules and changing analytical demands.


“This initiative represents more than an equipment replacement,” added Daniel Schulz-Jander, QPS Senior Director, Bioanalysis. “This strategic renewal of our ICP-MS systems ensures QPS maintains cutting-edge technology to deliver highly sensitive and robust analytical solutions for our clients' projects. This investment reinforces our ongoing commitment to providing exceptional elemental bioanalysis for both traditional and emerging drug development programs.”


QPS Netherlands has more than two decades of experience with ICP-MS-based bioanalysis. Its capabilities include total, free and trace elemental analysis, as well as LC-ICP-MS applications for speciation, stability and metabolite-related investigations. Installation, qualification, and phased implementation of the two NexION® 2200 systems are ongoing and scheduled to be completed in Q3 2026.


ABOUT QPS HOLDINGS, LLC


QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,200+ employees in the US, Europe, and Asia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, clinical trial units, central laboratory services, PBMC processing, and clinical research operations services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, and turnkey laboratories and facilities. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance, and trusted service to its valued customers. For more information, visit www.qps.com, email info@qps.com, or follow us on LinkedIn.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260831322534/en/



Permalink

https://www.aetoswire.com/en/news/3108202656966


Contacts

QPS:

Name: Gabrielle Pastore

Phone: 1-302-635-4290

Email: Gabrielle.Pastore@QPS.com